Pepcid 10 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

pepcid 10 mg

mcneil sweden ab - famotidin - tablett, filmdrasjert - 10 mg

Lamictal 200 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 200 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 200 mg

Lamictal 2 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 2 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 2 mg

Lamictal 5 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 5 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 5 mg

Lamictal 25 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 25 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 25 mg

Lamictal 50 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 50 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 50 mg

Lamictal 100 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

lamictal 100 mg

glaxosmithkline as - lamotrigin - tyggetablett/dispergerbar tablett - 100 mg

Pepcidduo 노르웨이 - 노르웨이어 - Statens legemiddelverk

pepcidduo

mcneil sweden ab - famotidin / magnesiumhydroksid / kalsiumkarbonat - tyggetablett med spearmintsmak - 10 mg / 165 mg / 800 mg

Paracetduo 500 mg / 65 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

paracetduo 500 mg / 65 mg

weifa as - paracetamol / koffein - brusetablett - 500 mg / 65 mg

Ontozry 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

ontozry

angelini pharma s.p.a - cenobamate - epilepsi - antiepileptics, - adjunctive treatment of focal-onset seizures with or without secondary generalisation in adult patients with epilepsy who have not been adequately controlled despite a history of treatment with at least 2 anti-epileptic medicinal products.